Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DRD3 Ser9Gly Polymorphism and Its Influence on Risperidone Response in Autistic Children.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques - 1 Jan 2017

Firouzabadi Negar, Nazariat Anna, Zomorrodian Kamiar

Abstract excerpt

PURPOSE: Autism, a neuropsychiatric illness, is a complex ailment of mainly indefinite cause. Although precise pathophysiological mechanism is unclear but the role of genetics is undeniable therefore pharmacogenetics may assist to a better management of symptoms. Risperidone is widely used in autism. Considering the significance of dopaminergic system in psychological and neurological diseases and its association...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autistic Disorder
Share to Glycine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptors, Dopamine D3

Share to Risperidone

Share to Serine

Share to Software

Share to Treatment Outcome

Source

Identifiers

PMID: 29249220
DOI: 10.18433/J3H63T

Genes

DRD3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DRD3 Ser9Gly Polymorphism and Its Influence on Risperidone Response in Autistic Children.PMID 29249220Read ↗

The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism.Semantic proximity Read ↗

Functional SLC6A3 polymorphisms differentially affect autism spectrum disorder severity: a study on Indian subjects.Semantic proximity Read ↗

Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implicationsSemantic proximity Read ↗

Association of GABRG3, GABRB3, HTR2A gene variants with autism spectrum disorder.Semantic proximity Read ↗

Genetic variants of neurotransmitter-related genes and miRNAs in Egyptian autistic patients.Semantic proximity Read ↗

Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.Semantic proximity Read ↗

Analysis of neurotransmitters validates the importance of the dopaminergic system in autism spectrum disorder.Semantic proximity Read ↗

Biomarker Variants of Dopamine Receptor Genes Influence the Binding Interaction Between Dopamine Receptor and Risperidone.Semantic proximity Read ↗

Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders.Semantic proximity Read ↗

Neuropilin-2 rs849563 gene variations and susceptibility to autism in Iranian population: A case-control study.Semantic proximity Read ↗

5-HT2A receptor gene polymorphisms in Croatian subjects with autistic disorder.Semantic proximity Read ↗

Association between autism spectrum disorder and polymorphisms in genes encoding serotine and dopamine receptors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.